Reimbursement
Turing Pharmaceuticals chief Martin Shkreli will face new competition for Daraprim, the AIDS drug he recently hiked 5,000 percent in price, after competitor Imprimis Pharmaceuticals said it would market a similar drug for just $1 a tablet.
The House has approved a budget reconciliation bill that repeals parts of the Affordable Care Act, including the individual and employer mandates, the "Cadillac tax," and the medical device tax.
Premiums will increase an average of 7.5 percent for the second-lowest-cost silver insurance plan to be offered next year in the 37 states where the federal government operates health marketplaces, according to an analysis by the Department of Health and Human Services.
Under the health law, health plans are required to cover preventive services that are recommended by the U.S. Preventive Services Task Force, a nonpartisan group of medical experts, without charging consumers anything out of pocket.
The medication therapy management model is being tested in five regions as an incentive to boost adherence for stand-alone Part D plans not connected with Medicare Advantage.
America's Health Insurance Plans on Wednesday called former Secretary of State Hillary Clinton's stance against major insurance company consolidation misguided, and suggested that the presidential candidate focus on other issues plaguing healthcare instead.
A key strategy for Medicare is encouraging doctors, hospitals and other health care providers to form accountable care organizations (ACOs) to coordinate beneficiaries' care and provide services more efficiently.
America's Health Insurance Plans on Wednesday called former Secretary of State Hillary Clinton's stance against major insurance company consolidation misguided, and suggested that the presidential candidate focus on other issues plaguing healthcare instead.
CMS has approved Dartmouth-Hitchcock's application for Next Generation and will receive its dollar target this fall. That will determine whether they sign the contract.
Aetna said it expects the transaction will be completed in the second half of 2016 pending conditions, federal review and regulatory approval.